K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M
2016
CMO
LEADERSHIP
AWARDS
WINNERS
Company
Profiles
LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2016
52
CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY
INDIVIDUAL ATTRIBUTE AWARDS: cultural fit,
on-time, right first time, state-of-the-art
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management
SERVICES & CAPABILITIES: aseptic fill/finish,
capsules, controlled substances, creams &
ointments, cytotoxic & high potency compounds,
generics, liquids, lyophilized products, nonsterile,
OTC, parenterals (large volume), parenterals
(small volume), peptides, powders (nonsterile),
powders (sterile), proteins, semisolids, soft gels,
solid dose, solutions & suspensions, sustained
release, topicals
"We are delighted to have received yet another
CMO Leadership Award for these three key
categories. We pride ourselves on our ability
to not only meet but exceed expectations to
our global clients by ensuring that we provide
exceptional and reliable quality in all aspects of
our work. These awards recognize that quality
determines the extent of our commitment and
success."
SERVICES & CAPABILITIES: APIs and HPAPIs,
controlled substances, cytotoxic & high potency
compounds, fine chemicals, generics, peptides,
registered intermediates
"AMPAC Fine Chemicals (AFC) has established a
heritage of successful transition from clinical to
commercial production, demanding production
quantity and highly energetic APIs.
AFC is a recognized partner supporting FDA Pre-
Approval Inspections for complex drug formulations,
commercial drug products, controlled substances,
high potency, and energetic compounds.
AFC has an aggressive growth program focused
on medium scale production quickly configured for
specific programs as well as large-scale capacity for
major batch and continuous operations."
SERVICES & CAPABILITIES: API development &
manufacture, physical & analytical chemistry
"Customers have noted our unique capabilities
in integrated discovery, integrated CMC, and
integrated development. Our growth program led
to a significant increase in capacity allowing us
to deliver more high-quality integrated CMC and
help our customers increase their chances of
successful IND filing. We are focused on helping
our customers discover, develop, and produce
drugs with very high quality, whilst minimizing
operational risks. We remain best in class for
scientific quality, speed, and cost."
DRUG TYPE:
Pharmaceuticals, Biopharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG LIFE CYCLE STAGES:
Research & Development: Discovery, Preclinical,
Clinical (Phase 1, Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Development, Dosage Form Production,
Packaging, Logistics
DRUG LIFE CYCLE STAGES:
Research & Development: Clinical (Phase 1,
Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
DRUG LIFE CYCLE STAGES:
Research & Development: Discovery, Preclinical
Drug Substance Production: Primary Process
Development
Formulated Drug Production: Dosage Form
Development
DRUG TYPE:
Pharmaceuticals
ALAN ARMSTRONG
CEO
ASLAM MALIK
President & CEO
JONATHAN GOLDMAN
CEO
CATEGORIES WON CATEGORIES WON CATEGORIES WON
Aptuit
Greenwich, CT
www.aptuit.com
+1 855 4 APTUIT [427 8848]
Dan Conlon
dan.conlon@aptuit.com
Key locations: Veroa, Italy; Oxford, UK
AMPAC Fine Chemicals
Rancho Cordova, CA
www.ampacfinechemicals.com
+1 916 357 6880
Patrick Park
afcbusdev@apfc.com
Key locations: Rancho Cordova, CA; La Porte, TX
Almac Group
Craigavon, Co. Armagh, UK
www.almacgroup.com
+02838332200
Jennifer Forsythe
jennifer.forsythe@almacgroup.com
Key locations: Craigavon, UK; Singapore;
Edinburgh; North Carolina, Pennsylvania,
San Francisco, U.S.A.